S. R. Choi, Preclinical Properties of 18F-AV-45: A PET Agent for A?? Plaques in the Brain, Journal of Nuclear Medicine, vol.50, issue.11, pp.50-1887, 2009.
DOI : 10.2967/jnumed.109.065284

A. P. Carpenter and . Jr, The use of the exploratory IND in the evaluation and development of 18F-PET radiopharmaceuticals for amyloid imaging in the brain: a review of one company's experience, Q J Nucl Med Mol Imaging, vol.53, issue.4, pp.387-93, 2009.

C. M. Clark, Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-beta plaques: a prospective cohort study, Lancet Neurol, issue.8, pp.11-669, 2012.

C. M. Clark, Use of Florbetapir-PET for Imaging ??-Amyloid Pathology, JAMA, vol.305, issue.3, pp.275-83, 2011.
DOI : 10.1001/jama.2010.2008

K. J. Lin, Whole-body biodistribution and brain PET imaging with [18F]AV-45, a novel amyloid imaging agent ??? a pilot study, Nuclear Medicine and Biology, vol.37, issue.4, pp.497-508, 2010.
DOI : 10.1016/j.nucmedbio.2010.02.003

D. F. Wong, In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18), J Nucl Med, issue.6, pp.51-913, 2010.

L. Saint-aubert, Cortical florbetapir-PET amyloid load in prodromal Alzheimer???s disease patients, EJNMMI Research, vol.3, issue.1, 2013.
DOI : 10.1001/archneurol.2011.105

V. Camus, Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment, European Journal of Nuclear Medicine and Molecular Imaging, vol.68, issue.4, pp.621-652, 2012.
DOI : 10.1007/s00259-011-2021-8

URL : https://hal.archives-ouvertes.fr/inserm-00726336

A. S. Fleisher, Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease, Arch Neurol, issue.11, pp.68-1404, 2011.

L. Joie and R. , Region-specific hierarchy between atrophy, hypometabolism, and betaamyloid (Abeta) load in Alzheimer's disease dementia beta-Amyloid burden in healthy aging: regional distribution and cognitive consequences, J Neurosci Neurology, vol.32, issue.116, pp.16265-73, 2012.

V. L. Villemagne, Amyloid imaging with (18)F-florbetaben in Alzheimer disease and other dementias, J Nucl Med, issue.8, pp.52-1210, 2011.

V. L. Villemagne, Comparison of 11C-PiB and 18F-florbetaben for Abeta imaging in ageing and Alzheimer's disease, Eur J Nucl Med Mol Imaging, issue.6, pp.39-983, 2012.

M. T. Fodero-tavoletti, Characterization of PiB Binding to White Matter in Alzheimer Disease and Other Dementias, Journal of Nuclear Medicine, vol.50, issue.2, pp.198-204, 2009.
DOI : 10.2967/jnumed.108.057984

B. Dubois, Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS???ADRDA criteria, The Lancet Neurology, vol.6, issue.8, pp.734-780, 2007.
DOI : 10.1016/S1474-4422(07)70178-3

D. Wallon, The French Series of Autosomal Dominant Early Onset Alzheimer's Disease Cases: Mutation Spectrum and Cerebrospinal Fluid Biomarkers, Journal of Alzheimers Disease, vol.30, issue.4, pp.847-856, 2012.

J. L. Fleiss, J. C. Nee, and J. R. Landis, Large sample variance of kappa in the case of different sets of raters., Psychological Bulletin, vol.86, issue.5, pp.974-977, 1979.
DOI : 10.1037/0033-2909.86.5.974

S. Kyriazi, Metastatic Ovarian and Primary Peritoneal Cancer: Assessing Chemotherapy Response with Diffusion-weighted MR Imaging???Value of Histogram Analysis of Apparent Diffusion Coefficients, Radiology, vol.261, issue.1, pp.182-92, 2011.
DOI : 10.1148/radiol.11110577

W. B. Pope, Recurrent Glioblastoma Multiforme: ADC Histogram Analysis Predicts Response to Bevacizumab Treatment, Radiology, vol.252, issue.1, pp.182-191, 2009.
DOI : 10.1148/radiol.2521081534

W. B. Pope, Apparent Diffusion Coefficient Histogram Analysis Stratifies Progression-Free Survival in Newly Diagnosed Bevacizumab-Treated Glioblastoma, American Journal of Neuroradiology, vol.32, issue.5, pp.882-891, 2011.
DOI : 10.3174/ajnr.A2385

W. J. Conover and R. L. Iman, [Rank Transformations as a Bridge Between Parametric and Nonparametric Statistics]: Rejoinder, The American Statistician, vol.35, issue.3, pp.132-133, 1981.
DOI : 10.2307/2683978

H. Barthel, Cerebral amyloid-?? PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study, The Lancet Neurology, vol.10, issue.5, pp.424-459, 2011.
DOI : 10.1016/S1474-4422(11)70077-1

E. Canu, Mapping the structural brain changes in Alzheimer's disease: the independent contribution of two imaging modalities, J Alzheimers Dis, vol.26, pp.263-74, 2011.

M. J. Firbank, Diffusion tensor imaging in Alzheimer's disease and dementia with Lewy bodies, Psychiatry Research: Neuroimaging, vol.194, issue.2, pp.176-83, 2011.
DOI : 10.1016/j.pscychresns.2011.08.002

R. Vandenberghe, Binary classification of 18F-flutemetamol PET using machine learning: Comparison with visual reads and structural MRI, NeuroImage, vol.64, pp.517-525, 2013.
DOI : 10.1016/j.neuroimage.2012.09.015

J. H. Kim, Regional white matter hyperintensities in normal aging, single domain amnestic mild cognitive impairment, and mild Alzheimer???s disease, Journal of Clinical Neuroscience, vol.18, issue.8, pp.18-1101, 2011.
DOI : 10.1016/j.jocn.2011.01.008

I. Makedonov, S. E. Black, and B. J. Macintosh, Cerebral small vessel disease in aging and Alzheimer's disease: a comparative study using MRI and SPECT, European Journal of Neurology, vol.33, issue.Suppl, pp.243-50, 2013.
DOI : 10.1111/j.1468-1331.2012.03785.x

L. L. Chao, Associations between white matter hyperintensities and beta amyloid on integrity of projection, association, and limbic fiber tracts measured with diffusion tensor MRI, PLoS One Amyloid Imaging With Carbon JAMA Neurol, vol.8, issue.6, 2013.

M. E. Gurol, Cerebral amyloid angiopathy burden associated with leukoaraiosis: A positron emission tomography/magnetic resonance imaging study Alzheimer's Disease Neuroimaging Initiative., Classification of structural MRI images in Alzheimer's disease from the perspective of ill-posed problems, Ann Neurol PLoS One, issue.10, pp.31-38, 2012.

W. Jagust, What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia? Neurology, pp.871-877, 2007.

E. Westman, J. S. Muehlboeck, and A. Simmons, Combining MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion, Alzheimer's & Dementia, vol.7, issue.4, pp.229-238, 2012.
DOI : 10.1016/j.jalz.2011.09.043

R. Wolz, Multi-Method Analysis of MRI Images in Early Diagnostics of Alzheimer's Disease, PLoS ONE, vol.54, issue.3, p.25446, 2011.
DOI : 10.1371/journal.pone.0025446.s002

T. Jeon, Regional changes of cortical mean diffusivities with aging after correction of partial volume effects, NeuroImage, vol.62, issue.3, pp.1705-1721, 2012.
DOI : 10.1016/j.neuroimage.2012.05.082

A. Stadlbauer, Magnetic resonance fiber density mapping of age-related white matter changes, European Journal of Radiology, vol.81, issue.12, pp.4005-4017, 2012.
DOI : 10.1016/j.ejrad.2012.05.029

H. Watanabe, Progression and prognosis in multiple system atrophy: an analysis of 230